Transfusion of Blood and Blood Products: Indications and Complications
Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. Transfusion of red blood cells should be based on the patient's clinical condition. Indications for transfusion include symptomatic anemia (causing shortness of breath, dizziness, congestive hear...
Gespeichert in:
Veröffentlicht in: | American family physician 2011-03, Vol.83 (6), p.719-724 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 724 |
---|---|
container_issue | 6 |
container_start_page | 719 |
container_title | American family physician |
container_volume | 83 |
creator | Sharma, Sanjeev, MD Sharma, Poonam, MD Tyler, Lisa N., MD |
description | Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. Transfusion of red blood cells should be based on the patient's clinical condition. Indications for transfusion include symptomatic anemia (causing shortness of breath, dizziness, congestive heart failure, and decreased exercise tolerance), acute sickle cell crisis, and acute blood loss of more than 30 percent of blood volume. Fresh frozen plasma infusion can be used for reversal of anticoagulant effects. Platelet transfusion is indicated to prevent hemorrhage in patients with thrombocytopenia or platelet function defects. Cryoprecipitate is used in cases of hypofibrinogenemia, which most often occurs in the setting of massive hemorrhage or consumptive coagulopathy. Transfusion-related infections are less common than noninfectious complications. All noninfectious complications of transfusion are classified as noninfectious serious hazards of transfusion. Acute complications occur within minutes to 24 hours of the transfusion, whereas delayed complications may develop days, months, or even years later. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_857482627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002838X1160097X</els_id><sourcerecordid>2308127091</sourcerecordid><originalsourceid>FETCH-LOGICAL-e292t-ff276f0d93c0872bdaf996c366907784d8fe2a72fef006c7042c409d52cdcb383</originalsourceid><addsrcrecordid>eNpdkEtLw0AUhQdRbK3-BQluXAVuZpJ5uBC0WC0UFKzQ3TCZB6QmmZpJhP57p7Z14eq-Pg73nBM0zgqCU6AFnKIxAOCUE74aoYsQ1nFkRSbO0QhnOeSCkzGaLTvVBjeEyreJd8lj7b1JVGsO3VvnzaD7cJfMW1Np1Ucu_N6nvtnUx80lOnOqDvbqUCfoY_a0nL6ki9fn-fRhkVoscJ86hxl1YATRwBkujXJCUE0oFcAYzw13FiuGnXUAVDPIsc5BmAJro0vCyQTd7nU3nf8abOhlUwVt61q11g9B8oLlHFPMInnzj1z7oWvjcxESMSRGSYSuD9BQNtbITVc1qtvKYz4RuN8DNpr6rmwndV210XX9abc2_ElmMmAJ8n2X-C7wLKMAgq3IDxUpdj0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>859532763</pqid></control><display><type>article</type><title>Transfusion of Blood and Blood Products: Indications and Complications</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Sharma, Sanjeev, MD ; Sharma, Poonam, MD ; Tyler, Lisa N., MD</creator><creatorcontrib>Sharma, Sanjeev, MD ; Sharma, Poonam, MD ; Tyler, Lisa N., MD</creatorcontrib><description>Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. Transfusion of red blood cells should be based on the patient's clinical condition. Indications for transfusion include symptomatic anemia (causing shortness of breath, dizziness, congestive heart failure, and decreased exercise tolerance), acute sickle cell crisis, and acute blood loss of more than 30 percent of blood volume. Fresh frozen plasma infusion can be used for reversal of anticoagulant effects. Platelet transfusion is indicated to prevent hemorrhage in patients with thrombocytopenia or platelet function defects. Cryoprecipitate is used in cases of hypofibrinogenemia, which most often occurs in the setting of massive hemorrhage or consumptive coagulopathy. Transfusion-related infections are less common than noninfectious complications. All noninfectious complications of transfusion are classified as noninfectious serious hazards of transfusion. Acute complications occur within minutes to 24 hours of the transfusion, whereas delayed complications may develop days, months, or even years later.</description><identifier>ISSN: 0002-838X</identifier><identifier>EISSN: 1532-0650</identifier><identifier>PMID: 21404983</identifier><identifier>CODEN: AFPYBF</identifier><language>eng</language><publisher>United States: American Academy of Family Physicians</publisher><subject>Acute Lung Injury - etiology ; Adult ; Anemia ; Blood platelets ; Blood products ; Blood Transfusion ; Blood transfusions ; Erythrocyte Transfusion - adverse effects ; Erythrocytes ; Graft vs Host Disease - etiology ; Hemolysis ; Hemorrhage ; Humans ; Infant, Newborn ; Infections ; Internal Medicine ; Transfusion Reaction</subject><ispartof>American family physician, 2011-03, Vol.83 (6), p.719-724</ispartof><rights>American Family Physician</rights><rights>Copyright American Academy of Family Physicians Mar 15, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21404983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharma, Sanjeev, MD</creatorcontrib><creatorcontrib>Sharma, Poonam, MD</creatorcontrib><creatorcontrib>Tyler, Lisa N., MD</creatorcontrib><title>Transfusion of Blood and Blood Products: Indications and Complications</title><title>American family physician</title><addtitle>Am Fam Physician</addtitle><description>Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. Transfusion of red blood cells should be based on the patient's clinical condition. Indications for transfusion include symptomatic anemia (causing shortness of breath, dizziness, congestive heart failure, and decreased exercise tolerance), acute sickle cell crisis, and acute blood loss of more than 30 percent of blood volume. Fresh frozen plasma infusion can be used for reversal of anticoagulant effects. Platelet transfusion is indicated to prevent hemorrhage in patients with thrombocytopenia or platelet function defects. Cryoprecipitate is used in cases of hypofibrinogenemia, which most often occurs in the setting of massive hemorrhage or consumptive coagulopathy. Transfusion-related infections are less common than noninfectious complications. All noninfectious complications of transfusion are classified as noninfectious serious hazards of transfusion. Acute complications occur within minutes to 24 hours of the transfusion, whereas delayed complications may develop days, months, or even years later.</description><subject>Acute Lung Injury - etiology</subject><subject>Adult</subject><subject>Anemia</subject><subject>Blood platelets</subject><subject>Blood products</subject><subject>Blood Transfusion</subject><subject>Blood transfusions</subject><subject>Erythrocyte Transfusion - adverse effects</subject><subject>Erythrocytes</subject><subject>Graft vs Host Disease - etiology</subject><subject>Hemolysis</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Internal Medicine</subject><subject>Transfusion Reaction</subject><issn>0002-838X</issn><issn>1532-0650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtLw0AUhQdRbK3-BQluXAVuZpJ5uBC0WC0UFKzQ3TCZB6QmmZpJhP57p7Z14eq-Pg73nBM0zgqCU6AFnKIxAOCUE74aoYsQ1nFkRSbO0QhnOeSCkzGaLTvVBjeEyreJd8lj7b1JVGsO3VvnzaD7cJfMW1Np1Ucu_N6nvtnUx80lOnOqDvbqUCfoY_a0nL6ki9fn-fRhkVoscJ86hxl1YATRwBkujXJCUE0oFcAYzw13FiuGnXUAVDPIsc5BmAJro0vCyQTd7nU3nf8abOhlUwVt61q11g9B8oLlHFPMInnzj1z7oWvjcxESMSRGSYSuD9BQNtbITVc1qtvKYz4RuN8DNpr6rmwndV210XX9abc2_ElmMmAJ8n2X-C7wLKMAgq3IDxUpdj0</recordid><startdate>20110315</startdate><enddate>20110315</enddate><creator>Sharma, Sanjeev, MD</creator><creator>Sharma, Poonam, MD</creator><creator>Tyler, Lisa N., MD</creator><general>American Academy of Family Physicians</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20110315</creationdate><title>Transfusion of Blood and Blood Products: Indications and Complications</title><author>Sharma, Sanjeev, MD ; Sharma, Poonam, MD ; Tyler, Lisa N., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e292t-ff276f0d93c0872bdaf996c366907784d8fe2a72fef006c7042c409d52cdcb383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Lung Injury - etiology</topic><topic>Adult</topic><topic>Anemia</topic><topic>Blood platelets</topic><topic>Blood products</topic><topic>Blood Transfusion</topic><topic>Blood transfusions</topic><topic>Erythrocyte Transfusion - adverse effects</topic><topic>Erythrocytes</topic><topic>Graft vs Host Disease - etiology</topic><topic>Hemolysis</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Internal Medicine</topic><topic>Transfusion Reaction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharma, Sanjeev, MD</creatorcontrib><creatorcontrib>Sharma, Poonam, MD</creatorcontrib><creatorcontrib>Tyler, Lisa N., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharma, Sanjeev, MD</au><au>Sharma, Poonam, MD</au><au>Tyler, Lisa N., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfusion of Blood and Blood Products: Indications and Complications</atitle><jtitle>American family physician</jtitle><addtitle>Am Fam Physician</addtitle><date>2011-03-15</date><risdate>2011</risdate><volume>83</volume><issue>6</issue><spage>719</spage><epage>724</epage><pages>719-724</pages><issn>0002-838X</issn><eissn>1532-0650</eissn><coden>AFPYBF</coden><abstract>Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. Transfusion of red blood cells should be based on the patient's clinical condition. Indications for transfusion include symptomatic anemia (causing shortness of breath, dizziness, congestive heart failure, and decreased exercise tolerance), acute sickle cell crisis, and acute blood loss of more than 30 percent of blood volume. Fresh frozen plasma infusion can be used for reversal of anticoagulant effects. Platelet transfusion is indicated to prevent hemorrhage in patients with thrombocytopenia or platelet function defects. Cryoprecipitate is used in cases of hypofibrinogenemia, which most often occurs in the setting of massive hemorrhage or consumptive coagulopathy. Transfusion-related infections are less common than noninfectious complications. All noninfectious complications of transfusion are classified as noninfectious serious hazards of transfusion. Acute complications occur within minutes to 24 hours of the transfusion, whereas delayed complications may develop days, months, or even years later.</abstract><cop>United States</cop><pub>American Academy of Family Physicians</pub><pmid>21404983</pmid><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-838X |
ispartof | American family physician, 2011-03, Vol.83 (6), p.719-724 |
issn | 0002-838X 1532-0650 |
language | eng |
recordid | cdi_proquest_miscellaneous_857482627 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Acute Lung Injury - etiology Adult Anemia Blood platelets Blood products Blood Transfusion Blood transfusions Erythrocyte Transfusion - adverse effects Erythrocytes Graft vs Host Disease - etiology Hemolysis Hemorrhage Humans Infant, Newborn Infections Internal Medicine Transfusion Reaction |
title | Transfusion of Blood and Blood Products: Indications and Complications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A48%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfusion%20of%20Blood%20and%20Blood%20Products:%20Indications%20and%20Complications&rft.jtitle=American%20family%20physician&rft.au=Sharma,%20Sanjeev,%20MD&rft.date=2011-03-15&rft.volume=83&rft.issue=6&rft.spage=719&rft.epage=724&rft.pages=719-724&rft.issn=0002-838X&rft.eissn=1532-0650&rft.coden=AFPYBF&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2308127091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=859532763&rft_id=info:pmid/21404983&rft_els_id=1_s2_0_S0002838X1160097X&rfr_iscdi=true |